Cincinnati Children's Hospital Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Cincinnati Children's Hospital Medical Center brings 2 presentations to ASH 2026 in New Orleans. Its program ranges from vascular anomalies and HLH, a hyperinflammatory syndrome, to relapse in acute myeloid leukemia. It also covers targeted drugs for vascular anomalies with RAS/MAPK pathway variants and lipid markers of AML relapse.
| Organization | ASH 2026 Attendance |
|---|---|
Cincinnati Children's Hospital Medical Center Cincinnati, OH | |
Pediatric academic medical center in Cincinnati, Ohio, with large programs in pediatric hematology, oncology and blood and marrow transplantation. | Talk Lipids Biomarkers of Therapy Relapse in Acute Myeloid Leukemia Using a patient's blood lipid profile to predict treatment response and relapse in acute myeloid leukemia, and targeting lipids to overcome drug resistance. Talk Targeted Therapies for Vascular Anomalies with RAS/MAPK Pathway Pathogenic Variants Treating fast-flow arteriovenous and complex lymphatic malformations driven by growth-signaling gene variants with repurposed cancer drugs such as trametinib. |
Instantly find 20 buyers from Cincinnati Children's Hospital Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction